FI875097A - Omaettade fosfonsyror samt deras derivat. - Google Patents

Omaettade fosfonsyror samt deras derivat. Download PDF

Info

Publication number
FI875097A
FI875097A FI875097A FI875097A FI875097A FI 875097 A FI875097 A FI 875097A FI 875097 A FI875097 A FI 875097A FI 875097 A FI875097 A FI 875097A FI 875097 A FI875097 A FI 875097A
Authority
FI
Finland
Prior art keywords
carbon
omaettade
fosfonsyror
carboxyl
compounds
Prior art date
Application number
FI875097A
Other languages
English (en)
Other versions
FI86638C (fi
FI875097A0 (fi
FI86638B (fi
Inventor
Alan J Hutchison
Kenneth R Shaw
Josef A Schneider
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of FI875097A0 publication Critical patent/FI875097A0/fi
Publication of FI875097A publication Critical patent/FI875097A/fi
Application granted granted Critical
Publication of FI86638B publication Critical patent/FI86638B/fi
Publication of FI86638C publication Critical patent/FI86638C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • C07D211/12Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with only hydrogen atoms attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576Six-membered rings
    • C07F9/60Quinoline or hydrogenated quinoline ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/572Five-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576Six-membered rings
    • C07F9/59Hydrogenated pyridine rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Dental Preparations (AREA)
FI875097A 1986-11-21 1987-11-18 Foerfarande foer framstaellning av terapeutiskt effektiva omaettade fosfonsyror. FI86638C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US93370286A 1986-11-21 1986-11-21
US93370286 1986-11-21

Publications (4)

Publication Number Publication Date
FI875097A0 FI875097A0 (fi) 1987-11-18
FI875097A true FI875097A (fi) 1988-05-22
FI86638B FI86638B (fi) 1992-06-15
FI86638C FI86638C (fi) 1992-09-25

Family

ID=25464377

Family Applications (1)

Application Number Title Priority Date Filing Date
FI875097A FI86638C (fi) 1986-11-21 1987-11-18 Foerfarande foer framstaellning av terapeutiskt effektiva omaettade fosfonsyror.

Country Status (21)

Country Link
EP (1) EP0275820B1 (fi)
JP (1) JPH0686470B2 (fi)
KR (1) KR880006195A (fi)
AT (1) ATE60776T1 (fi)
AU (1) AU610841B2 (fi)
CA (1) CA1312608C (fi)
DD (1) DD273837A5 (fi)
DE (1) DE3768000D1 (fi)
DK (1) DK609487A (fi)
ES (1) ES2031927T3 (fi)
FI (1) FI86638C (fi)
GR (1) GR3001443T3 (fi)
HU (1) HU199857B (fi)
IE (1) IE60534B1 (fi)
IL (1) IL84492A0 (fi)
MX (1) MX9437A (fi)
NO (1) NO170853C (fi)
NZ (1) NZ222607A (fi)
PH (1) PH25465A (fi)
PT (1) PT86168B (fi)
ZA (1) ZA878699B (fi)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4968678A (en) * 1988-02-19 1990-11-06 Eli Lilly And Company Tetrazole excitatory amino acid receptor antagonists
CA2000901A1 (en) * 1988-10-21 1990-04-21 Alexis A. Cordi Phosphono-hydroisoquinoline compounds useful in reducing neurotoxic injury
US4902695A (en) * 1989-02-13 1990-02-20 Eli Lilly And Company Excitatory amino acid receptor antagonists
EP0424179A3 (en) * 1989-10-20 1991-12-27 John William Olney Use of combined excitatory amino acid and cholinergic antagonists to prevent neurological deterioration
US5238958A (en) * 1990-02-26 1993-08-24 Warner-Lambert Company Substituted α-amino acids having selected acidic moieties for use as excitatory amino acid antagonists in pharmaceuticals
US5194430A (en) * 1990-05-17 1993-03-16 Merrell Dow Pharmaceuticals Inc. Heterocyclic-nmda antagonists
SE9003652D0 (sv) * 1990-11-15 1990-11-15 Astra Ab New heterocyclic compounds
US5260286A (en) * 1992-10-16 1993-11-09 Japan Tobacco, Inc. 2-piperidinecarboxylic acid derivatives useful as NMDA receptor antagonists
NZ501714A (en) 1997-06-12 2001-09-28 Rhone Poulenc Rorer Ltd Imidazolyl-cyclic acetal derivatives, resins and intermediates thereof and use as TNF inhibitors
EP3427729A1 (en) 2017-07-13 2019-01-16 Paris Sciences et Lettres - Quartier Latin Probenecid for use in treating epileptic diseases, disorders or conditions

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2104079B (en) * 1981-08-14 1985-08-21 London Polytech New aminoacid isomers, their production and their medicinal use
PH23848A (en) * 1985-05-24 1989-11-23 Ciba Geigy Ag Certain phosphonic acids and derivatives

Also Published As

Publication number Publication date
DK609487D0 (da) 1987-11-20
IE60534B1 (en) 1994-07-27
JPH01135791A (ja) 1989-05-29
EP0275820A3 (en) 1988-08-03
PT86168A (en) 1987-12-01
ATE60776T1 (de) 1991-02-15
EP0275820A2 (de) 1988-07-27
FI86638C (fi) 1992-09-25
HU199857B (en) 1990-03-28
GR3001443T3 (en) 1992-09-25
PH25465A (en) 1991-07-01
KR880006195A (ko) 1988-07-22
NO170853C (no) 1992-12-16
NO170853B (no) 1992-09-07
NO874854L (no) 1988-05-24
AU8145587A (en) 1988-05-26
IE873149L (en) 1988-05-21
IL84492A0 (en) 1988-04-29
ZA878699B (en) 1988-05-23
DD273837A5 (de) 1989-11-29
HUT46331A (en) 1988-10-28
PT86168B (pt) 1990-08-31
CA1312608C (en) 1993-01-12
FI875097A0 (fi) 1987-11-18
AU610841B2 (en) 1991-05-30
ES2031927T3 (es) 1993-01-01
DK609487A (da) 1988-05-22
NZ222607A (en) 1990-10-26
DE3768000D1 (de) 1991-03-14
MX9437A (es) 1994-01-31
EP0275820B1 (de) 1991-02-06
NO874854D0 (no) 1987-11-20
JPH0686470B2 (ja) 1994-11-02
FI86638B (fi) 1992-06-15

Similar Documents

Publication Publication Date Title
FI862093A (fi) Fosfonsyror och deras derivat.
FI875097A (fi) Omaettade fosfonsyror samt deras derivat.
ES2000368A6 (es) Un procedimiento para preparar di-t-butilfenoles sustituidos
FI881892A0 (fi) Menetelmä uusien, terapeuttisesti käyttökelpoisten 1,2,5,6-tetrahydropyridiinijohdannaisten valmistamiseksi
SE8200570L (sv) Tiazolidinderivat med farmakologisk aktivitet samt forfarande for framstellning derav
ES2053865T3 (es) Utilizacion de compuestos etanosulfonicos 2-sustituidos como productos galvanotecnicos auxiliares.
ES2053868T3 (es) 3-aminosidnoniminas substituidas, procedimientos para su obtencion y su empleo.
ES2000369A6 (es) Un procedimiento para preparar di-t-butilfenoles sustituidos

Legal Events

Date Code Title Description
BB Publication of examined application
PC Transfer of assignment of patent

Owner name: NOVARTIS AG

MM Patent lapsed
MM Patent lapsed

Owner name: NOVARTIS AG